✦ LIBER ✦

Molecular therapies for malignant glioma

✍ Scribed by Markus Hutterer; Eberhard Gunsilius; Guenther Stockhammer

Publisher: Springer Vienna
Year: 2006
Tongue: German
Weight: 396 KB
Volume: 156
Category: Article
ISSN: 0043-5341
DOI: 10.1007/s10354-006-0308-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Signal transduction inhibitors and antia

Signal transduction inhibitors and antiangiogenic therapies for malignant glioma

✍ Ingo K. Mellinghoff; Andrew B. Lassman; Patrick Y. Wen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 1 views

## Abstract Detailed characterization of the cancer genome in a large number of primary human glioblastomas has identified recurrent alterations that result in deregulation of signal transduction pathways and are “druggable” with a growing number of small molecule pharmaceuticals. While many of the

Molecularly targeted therapy for maligna

Molecularly targeted therapy for malignant glioma

✍ Sith Sathornsumetee; David A. Reardon; Annick Desjardins; Jennifer A. Quinn; Jam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 1 views

## Abstract Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained dismal. Understanding the molecular pathogenesis of glioma may lead to a rational development of new therapies.

Angiogenesis and antiangiogenic therapy

Angiogenesis and antiangiogenic therapy for malignant gliomas

✍ Shingo Takano; Hiroshi Kamiyama; Koji Tsuboi; Akira Matsumura 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 404 KB

Molecularly targeted therapies for gliom

Molecularly targeted therapies for glioma

✍ Ryuya Yamanaka; Hideyuki Saya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

Oncolytic Viral Therapy of Malignant Gli

Oncolytic Viral Therapy of Malignant Glioma

✍ Jacqueline Nuss Parker; David F. Bauer; James J. Cody; James M. Markert 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 114 KB

Novel approaches to treatment of malignant glioma, the most frequently occurring primary brain tumor, have included the use of a wide range of oncolytic viral vectors. These vectors, either naturally tumor-selective, or engineered as such, have shown promise in the handful of phase I and phase II cl

Mitochondria-bound hexokinase as target

Mitochondria-bound hexokinase as target for therapy of malignant gliomas

✍ Stéphane Oudard; Florence Poirson; Laurent Miccoli; Yveline Bourgeois; Anne Vass 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 806 KB

Hexokinase plays an important role in glucose-utilizing tissues like normal brain and cancers. In these tissues, hexokinase (HK) is mainly bound to mitochondria (mHK). Our objectives were to evaluate total HK (tHK) activity and mHK fraction in gliomas and to determine whether mHK binding could be ta